Germanytechnology-infrastructure.evonik.de/sites/siteservices/en/Pages/default.aspx
Its roles Owner Operator
Evonik Operations GmbH is the main operating company of Evonik Industries AG, a German specialty chemicals group. It consolidates most of Evonik’s global production, sales, and R&D activities. Headquartered in Essen, Germany, the company operates an international network of manufacturing sites and technology centers, including major operations at Marl Chemical Park.
The portfolio spans specialty additives, silica and silanes, high-performance polymers and intermediates, catalysts, animal nutrition amino acids, and healthcare excipients and drug‑delivery polymers. Evonik Operations GmbH supplies materials to sectors such as pharmaceuticals and biotechnology, coatings and adhesives, mobility and automotive, construction, electronics, agriculture, and consumer goods, supporting a wide range of industrial applications.
None yet. When a new project in the record names Evonik Operations GmbH as owner, partner or investor, it shows here.
Around 90 employees affected; Hamburg roles to shift to Essen, Bitterfeld closure set for end‑April 2027; customer supply to larger German sites; employee talks planned.
The EU funds next-gen flu vaccines to enhance protection, speed up development, and improve pandemic readiness through pre-commercial procurement.
Evonik earns the kununu Top Company Award for the fifth consecutive year, reflecting high employee satisfaction based on independent reviews.
EUDRACAP® colon capsules enable safe oral delivery of sensitive APIs, accelerating drug development for conditions like obesity and colorectal cancer.
A new plant will produce eMethanol using CO2 capture and green hydrogen, enhancing sustainable initiatives at Marl Chemical Park, with operations starting in 2026.
active all projects
